We're dedicated to improving lives through innovative medicines.
Our deep understanding of critical care, emergency medicine, and gastroenterology drives effective solutions.
We're committed to research and development for cutting-edge therapies.
Adduco Pharmaceuticals Pvt Ltd is a pharmaceutical company focused on improving patients’ lives by identifying, developing, and commercializing meaningful products that address unmet medical needs.
We have a diverse portfolio of products and product candidates, with a focus in the areas of Critical Care, Emergency Medicine and Gastroenterology. We also support commercial products in other therapeutic areas where we can meaningfully address serious medical needs.
As part of our unwavering commitment to improve patients’ lives, we are continuing to expand our commercial product portfolio and our research and development.
Pipeline in therapeutic areas that can leverage our unique expertise. We do this through a growth strategy of growing sales of the existing medicines in our portfolio, acquiring commercial products or product candidates that are in late-stage development; and pursuing focused development of our pipeline of differentiated therapies.
Our mission is to become the most valued and trusted company to patients, customers, colleagues, stake holders and the society.
To be a globally integrated pharmaceutical company through Innovation, Quality and Competence.
Our team of seasoned professionals has extensive experience in pharmaceutical marketing, ensuring tailored strategies that meet your needs.
We prioritize patient needs, developing campaigns that resonate and drive meaningful engagement.
Leveraging cutting-edge technology, data analytics, and creative storytelling to elevate your brand.
Extensive network and partnerships enable us to deliver international campaigns
Adduco Pharmaceuticals Private limited headquartered at Ghaziabad (India) is a global integrated pharmaceutical company offering a wide range of products and services to our customers across geographies.